Mirabegron: potential off target effects and uses beyond the bladder
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mirabegron: potential off target effects and uses beyond the bladder
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2017-12-16
DOI
10.1111/bph.14121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Additive Effect of Promoting Thermogenic Gene Expression in Mice Adipose-Derived Stromal Vascular Cells by Combination of Rosiglitazone and CL316,243
- (2017) You-Lei Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- How β3 -adrenoceptor-selective is mirabegron?
- (2016) Martin C Michel BRITISH JOURNAL OF PHARMACOLOGY
- Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade
- (2016) E C Alexandre et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives
- (2016) Monique Groen-Wijnberg et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial
- (2016) Henning Bundgaard et al. EUROPEAN JOURNAL OF HEART FAILURE
- β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project
- (2016) Martin C. Michel et al. PHARMACOLOGY & THERAPEUTICS
- Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor Agonist
- (2015) Aaron M. Cypess et al. Cell Metabolism
- Involvement of β3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: Direct evidence by [3H]-acetylcholine release experiments in the isolated detrusor
- (2015) Gianluigi D׳Agostino et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
- (2015) Tomonori Yamanishi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction
- (2015) Koji Ichihara et al. JOURNAL OF UROLOGY
- Could burning fat start with a brite spark? Pharmacological and nutritional ways to promote thermogenesis
- (2015) Jon Merlin et al. MOLECULAR NUTRITION & FOOD RESEARCH
- On the mode of action of mirabegron
- (2015) Karl-Erik Andersson Nature Reviews Urology
- β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase
- (2015) Hana Cernecka et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
- (2015) Christopher Southan et al. NUCLEIC ACIDS RESEARCH
- Diet-induced obesity causes insulin resistance in mouse brown adipose tissue
- (2015) Carla Roberts-Toler et al. Obesity
- Urodynamic Evaluation of the Efficacy of Mirabegron on Storage and Voiding Functions in Women With Overactive Bladder
- (2015) Yoshihisa Matsukawa et al. UROLOGY
- The beta-3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: New therapeutic indication?
- (2014) Fabiano B. Calmasini et al. PROSTATE
- Enhanced Expression of β3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase
- (2013) Catharina Belge et al. CIRCULATION
- The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol
- (2013) Walter Krauwinkel et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
- (2013) Khaled Maman et al. EUROPEAN UROLOGY
- The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials
- (2013) Yuanshan Cui et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Evidence for two types of brown adipose tissue in humans
- (2013) Martin E Lidell et al. NATURE MEDICINE
- In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats
- (2013) Toshiki Hatanaka et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys
- (2013) Toshiki Hatanaka et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans
- (2013) Janne Orava et al. Obesity
- Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study
- (2012) M Malik et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women
- (2012) Walter Krauwinkel et al. CLINICAL THERAPEUTICS
- The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity
- (2012) Julie Svalø et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
- (2012) Christopher R. Chapple et al. EUROPEAN UROLOGY
- Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder
- (2012) Victor W. Nitti et al. JOURNAL OF UROLOGY
- In vitroinhibition and induction of human cytochrome P450 enzymes by mirabegron, a potent and selective β3-adrenoceptor agonist
- (2012) Shin Takusagawa et al. XENOBIOTICA
- Identification of human cytochrome P450 isoforms and esterases involved in the metabolism of mirabegron, a potent and selective β3-adrenoceptor agonist
- (2012) Shin Takusagawa et al. XENOBIOTICA
- Brown Adipose Tissue in Morbidly Obese Subjects
- (2011) Guy H. E. J. Vijgen et al. PLoS One
- Are there functional β3-adrenoceptors in the human heart?
- (2010) Martin C Michel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cold-Activated Brown Adipose Tissue in Healthy Men
- (2009) Wouter D. van Marken Lichtenbelt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and Importance of Brown Adipose Tissue in Adult Humans
- (2009) Aaron M. Cypess et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started